Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00503347
Status:
COMPLETED
Last Update Posted:
2011-06-09
First Post:
2007-07-16
Brief Title:
Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus
Sponsor:
Peregrine Pharmaceuticals
Organization:
Peregrine Pharmaceuticals
Organization Data
Organization:
Peregrine Pharmaceuticals
Class:
INDUSTRY
Study ID:
PPHM 0603
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peregrine Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Jill Capps Clinical Program Manager
Old Organization:
Peregrine Pharmaceuticals